A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and ...

The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

In the study, "A wearable repetitive transcranial magnetic stimulation device," published in Nature Communications, researchers developed and tested a portable brain stimulation system by combining ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

The transcranial direct current stimulation (tDCS) technique involves placing electrodes on the patient's skull. The prefrontal montage used in this study (left) represents the electric field ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...